HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong Ren Selected Research

Telbivudine

1/2020Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy.
8/2015Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B.
4/2014The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study.
1/2014Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients.
1/2013Comparison of the forty-eight week efficacy between telbivudine and entecavir in HBeAg-positive Asian patients with chronic hepatitis B: A meta-analysis.
9/2008[Short-term results of telbivudine versus entecavir treatments in HBeAg-positive chronic hepatitis B patients in China].
2/2008Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.
5/2007[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong Ren Research Topics

Disease

82Chronic Hepatitis B
01/2022 - 02/2002
74Neoplasms (Cancer)
03/2022 - 08/2004
54Infections
12/2021 - 07/2005
29Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2002
23Hepatitis B
01/2021 - 03/2003
21Breast Neoplasms (Breast Cancer)
01/2021 - 04/2006
18Fibrosis (Cirrhosis)
09/2022 - 03/2003
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021 - 08/2009
13Lung Neoplasms (Lung Cancer)
10/2021 - 02/2010
13Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2021 - 05/2009
12Inflammation (Inflammations)
09/2022 - 06/2011
12Liver Cirrhosis (Hepatic Cirrhosis)
02/2022 - 02/2002
11Stomach Neoplasms (Stomach Cancer)
01/2022 - 05/2006
10Carcinogenesis
10/2021 - 01/2011
10Chronic Hepatitis C
03/2021 - 08/2007
10Neoplasm Metastasis (Metastasis)
01/2020 - 06/2005
10Proteinuria
12/2018 - 03/2012
9Chronic Kidney Failure (Chronic Renal Failure)
10/2022 - 01/2009
9Adenocarcinoma of Lung
03/2022 - 04/2017
7Disease Progression
01/2020 - 12/2007
7Vasculitis (Vasculitides)
01/2017 - 12/2007
6Esophageal Neoplasms (Esophageal Cancer)
12/2022 - 04/2012
6Liver Neoplasms (Liver Cancer)
09/2022 - 09/2005
6Sepsis (Septicemia)
01/2022 - 03/2019
6Liver Diseases (Liver Disease)
01/2022 - 02/2008
6IGA Glomerulonephritis (IGA Nephropathy)
01/2019 - 05/2006
5Hepatitis
09/2022 - 03/2004
5Carcinoma (Carcinomatosis)
05/2021 - 09/2011
5Kidney Diseases (Kidney Disease)
01/2020 - 06/2014
4Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
01/2021 - 01/2015
4Nephrotic Syndrome (Syndrome, Nephrotic)
01/2020 - 01/2011
4Peritonitis
05/2019 - 06/2004
4Glomerulonephritis
03/2017 - 12/2007
4Membranous Glomerulonephritis (Membranous Nephropathy)
03/2017 - 01/2013
4Lymphatic Metastasis
04/2016 - 02/2010
3Lupus Nephritis
10/2022 - 07/2007
3Cicatrix (Scar)
02/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

40Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2003
34Hepatitis B e AntigensIBA
05/2020 - 02/2002
29Hepatitis B Surface Antigens (HBsAg)FDA Link
05/2020 - 04/2003
28Antiviral Agents (Antivirals)IBA
01/2022 - 02/2002
25InterferonsIBA
03/2021 - 03/2003
19Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2012
18Lamivudine (Epivir)FDA Link
01/2019 - 03/2003
17DNA (Deoxyribonucleic Acid)IBA
01/2022 - 07/2003
17entecavirFDA Link
11/2021 - 01/2007
17VaccinesIBA
01/2021 - 04/2003
12Pharmaceutical PreparationsIBA
01/2022 - 01/2008
11Messenger RNA (mRNA)IBA
01/2020 - 09/2005
10MicroRNAs (MicroRNA)IBA
01/2020 - 05/2013
9Biological ProductsIBA
09/2022 - 01/2011
9Cisplatin (Platino)FDA LinkGeneric
01/2022 - 07/2008
9NucleosidesIBA
11/2021 - 01/2007
9AntigensIBA
01/2021 - 03/2003
8CreatinineIBA
10/2022 - 03/2012
8Alanine Transaminase (SGPT)IBA
01/2022 - 09/2012
8Therapeutic UsesIBA
01/2022 - 02/2003
8TelbivudineFDA Link
01/2020 - 05/2007
7RNA (Ribonucleic Acid)IBA
12/2021 - 05/2011
7SteroidsIBA
01/2020 - 01/2013
7CytokinesIBA
03/2018 - 06/2002
7Phosphotransferases (Kinase)IBA
01/2018 - 04/2006
7CalciumIBA
08/2017 - 02/2007
6Long Noncoding RNAIBA
03/2022 - 06/2016
6Ribavirin (Virazole)FDA LinkGeneric
03/2021 - 08/2007
6Serum AlbuminIBA
09/2017 - 02/2003
5Indicators and Reagents (Reagents)IBA
12/2022 - 06/2015
5AntibodiesIBA
12/2022 - 03/2004
5Interleukin-6 (Interleukin 6)IBA
10/2022 - 06/2013
5Tenofovir (Viread)FDA Link
11/2021 - 08/2011
5adefovirIBA
01/2020 - 05/2010
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2018 - 12/2007
5CurcuminIBA
03/2018 - 06/2011
5Hemoglobins (Hemoglobin)IBA
01/2018 - 01/2012
5Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2017 - 12/2007
5Caspase 3 (Caspase-3)IBA
01/2016 - 02/2010
4Tacrolimus (Prograf)FDA LinkGeneric
10/2022 - 04/2012
4LipidsIBA
09/2022 - 06/2013
4LigandsIBA
02/2022 - 05/2015
4LipopolysaccharidesIBA
01/2022 - 05/2015
4Interleukin-10 (Interleukin 10)IBA
01/2022 - 03/2015
4Anti-Bacterial Agents (Antibiotics)IBA
10/2021 - 08/2014
4CaspasesIBA
05/2021 - 06/2015
4AlbuminsIBA
10/2020 - 01/2012
4Cadherins (E-Cadherin)IBA
01/2020 - 01/2013
4Collagen Type IV (Type IV Collagen)IBA
08/2019 - 05/2004
4Triglycerides (Triacylglycerol)IBA
09/2017 - 01/2017
4EnzymesIBA
07/2017 - 02/2004
4Antigen-Antibody Complex (Immune Complex)IBA
01/2017 - 12/2007
4Caspase 8 (Caspase-8)IBA
10/2016 - 01/2012
4AutoantibodiesIBA
01/2016 - 12/2007
4ProteomeIBA
12/2015 - 03/2010
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2013 - 02/2006
3Mycophenolic Acid (Cellcept)FDA LinkGeneric
10/2022 - 07/2007
3Urea (Carbamide)FDA LinkGeneric
01/2022 - 09/2017
3Carbon Tetrachloride (Tetrachloromethane)IBA
01/2022 - 07/2017

Therapy/Procedure

72Therapeutics
10/2022 - 06/2002
11Drug Therapy (Chemotherapy)
04/2018 - 07/2008
6Immunotherapy
01/2021 - 05/2003
5Peritoneal Dialysis
05/2019 - 01/2010